Clinical Trial

Pilot Study on the Effectiveness of a Flexible Hydroxyapatite-Based Composite for Jaw Bone Regeneration

Study acronym: Flexi2024
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
Following a review of the scientific literature, it was found that there are no clinical studies but only in vitro and in vivo studies, which show promising results in terms of bone formation and integration. However, it is necessary to evaluate how well the regenerated bone maintains its structural integrity over time, considering masticatory function and real-life biomechanics. Factors such as mechanical load, remodeling dynamics, and interactions with surrounding tissues could influence the long-term stability of the regenerated bone. Additionally, another important aspect to study is the potential complications and adverse effects associated with the use of the flexible HAp-based composite.
Trial Details
NCT Number NCT06552715
Lead Sponsor University of Bologna
Conditions Bone Atrophy, Edentulism, Bone Regeneration
Enrollment 20 participants
Start Date 2024-09
Primary Completion 2025-04 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2024-08-14